You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Toremifene

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Breast Cancer, Quality of Life Trial in Chapel Hill (Accelerated Partial Breast Irradiation (APBI), tamoxifen, anastrozole,

Recruiting
  • Breast Cancer
  • Quality of Life
  • Accelerated Partial Breast Irradiation (APBI)
  • tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene
  • Chapel Hill, North Carolina
    University of North Carolina
Jul 22, 2022

Covid19 Trial (Toremifene, Melatonin, Placebo)

Withdrawn
  • Covid19
  • Toremifene
  • +2 more
  • (no location specified)
May 5, 2021

Breast Cancer Trial in Saint - Petersburg (metformin, Melatonin, Toremifene)

Unknown status
  • Breast Cancer
  • Saint - Petersburg, Russian Federation
    N.N. Petrov Research Institute of Oncology Clinical Diagnostic D
Sep 2, 2019

Breast Cancer Trial in Shanghai (Toremifene, Tamoxifen)

Completed
  • Breast Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Sep 23, 2019

Duration on Clinical Outcome of HR+ Intraductal Carcinoma of

Active, not recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    The First Hospital of China Medical University
Dec 10, 2020

Breast Cancer Stage I Trial (Capecitabine,Pyrotinib)

Not yet recruiting
  • Breast Cancer Stage I
  • (no location specified)
May 7, 2023

Breast Cancer Treatment Based on Organ-like Culture

Unknown status
  • Breast Cancer Organoids
  • Xi'an, Shaanxi, China
    JingSu
Apr 23, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Breast Cancer Trial (capecitabine and trastuzumab, endocrine therapy and trastuzumab)

Not yet recruiting
  • Breast Cancer
  • capecitabine and trastuzumab
  • endocrine therapy and trastuzumab
  • (no location specified)
May 7, 2020

HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal Trial in Seattle (Anastrozole, Exemestane, Laboratory Biomarker

Withdrawn
  • HER2/Neu Negative
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 26, 2018

Ovarian Cancer Trial in Washington, D.C. (toremifene)

Withdrawn
  • Ovarian Cancer
  • toremifene
  • Washington, D.C., District of Columbia
    George Washington University Cancer Center
Jul 11, 2017

Breast Cancer Female Trial in China (Tamoxifen, Toremifene)

Recruiting
  • Breast Cancer Female
  • Beijing, Beijing, China
  • +20 more
Nov 20, 2017

Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)

Completed
Has Results
  • Urothelial Carcinoma
  • +2 more
  • 75 approved agents
  • COXEN
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 14, 2020

Female Breast Cancer Trial in Beijing (Toremifene; Anastrozole)

Unknown status
  • Female Breast Cancer
  • Toremifene; Anastrozole
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 30, 2016

Normal Healthy Volunteers Trial in Rochester (Toremifene, Placebo, GHRH/Ghrelin combined Injection)

Completed
  • Normal Healthy Volunteers
  • Toremifene
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 12, 2016

Breast Cancer Trial in Beijing (Anastrozole, Tamoxifen, Toremifene)

Recruiting
  • Breast Cancer
  • Beijing, China
    Peking Union Medical College Hospital
May 24, 2016

Neuromuscular Monitoring, Sugammadex Effect Trial in Ankara (Neuromuscular monitorisation)

Completed
  • Neuromuscular Monitoring
  • Sugammadex Effect
  • Neuromuscular monitorisation
  • Ankara, Turkey
    Ankara University Faculty of Medicine, Ibni Sina Hospital OR
Aug 6, 2018

Prostate Cancer Trial in Pittsburgh (toremifene, conventional surgery, neoadjuvant therapy)

Completed
  • Prostate Cancer
  • toremifene
  • +2 more
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center at University of Pittsburgh Cancer Institu
Dec 1, 2015

Breast Cancer Trial in Hangzhou (Capecitabine, endocrine therapy)

Unknown status
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 27, 2017

Desmoid Type-fibromatosis Trial in Milan (Toremifene)

Unknown status
  • Desmoid Type-fibromatosis
  • Toremifene
  • Milan, Italy
    Fondazione IRCCS Istituto Tumori Milano
Jan 30, 2015

Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)

Completed
  • Atrial Fibrillation
  • São Paulo, Brazil
    Hospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016

Breast Tumors, Tumors, Hormone-dependent Trial in Worldwide (atamestane, toremifene, letrozole)

Completed
  • Breast Neoplasms
  • Neoplasms, Hormone-dependent
  • Lake Havasu City, Arizona
  • +62 more
Jul 29, 2015

Infertility Trial (Tamoxifen, Clomiphene)

Unknown status
  • Infertility
  • (no location specified)
Feb 23, 2016